Health Scientific Conference on the benefits of Fagaricine

Natural product designed to fight against the immunosuppression, the Fagaricine has been a scientific conference, hosted on March 24 in Brazzaville by its inventor Prof. Bruno Eto. The conference under the theme "clinical benefits of Fagaricine" was organized by Laboratoires Transcell TBC-Lab of the Faculty of Medicine Xavier Bichat in Paris (France), in partnership with the Fondation Congo Assistance (CFA).
The Fagaricine suffered multicenter clinical observations. According to Prof. Eto studies conducted in countries such as the Republic of the Congo, Côte d'Ivoire, Libya, Gabon, the Democratic Republic of Congo (DRC), Cameroon and France, show that this is a major asset for people living with HIV / AIDS. Apart from its role in strengthening the immune system of the body, this plant used in traditional medicine, fight viruses. Prof. Eto stated that studies of 75 people living with HIV AIDS in the Republic of Congo ( ranging in age from 28 to 42 years), have yielded positive results. It is a drug that has no side effects, from a called the Fagara. Plant "The fagaricine plays an important role in the defense when infected by AIDS. It is a powerful natural immune opening new perspectives for the treatment of AIDS patients. The Fagaricine is one of the first drugs from traditional medicine that manages to get the amenities of the WHO Africa and OAPI, "explained Professor Eto. added: "It is not a antiretroviral who fight against the virus itself, but clinical tests have shown that this is an immunostimulant. Immunocompromised individuals with all other diseases of informal and all other diseases that destroy the body's defenses are concerned with taking this medication. " He stressed the high cost of ARV triple therapy in France at least 1200 euros per month against 60 euros per month for the treatment of Fagaricine. "If the state could still give subsidies, it would cost less than 50 euros per month because we are still in the industrial phase. Small quantities are expensive and when we will increase the production rate, it will cost less. It really is a drug for people who do not have the means to heal, "said Prof. Eto, university and winner of the Prix Galien Research Africa.

news Image: